Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 22 11 2020
revised: 21 01 2021
accepted: 22 01 2021
entrez: 24 2 2021
pubmed: 25 2 2021
medline: 22 6 2021
Statut: ppublish

Résumé

The aim of this case report was to detail diagnosis and therapy in a case of implant-associated peripheral giant cell granuloma (IA-PGCG) of the jaw. Case Report: The 41-year-old female attended the outpatient clinic for treatment of recurrent mandibular IA-PGCG. The lesion was excised and the defect was closed with a connective tissue graft of the palate. Healing of oral defects was uneventful, and no local recurrence has occurred during a follow-up of 7 months. Genetic examination of the lesion identified a somatic mutation in KRAS. Conclusion: The lesions are assessed as reactive-inflammatory changes in the mucous membrane of the oral cavity. The cause of the lesion is unknown. KRAS mutations are commonly found in various cancer tissues, but also in germline and mosaic RASopathies. Recently, KRAS mutations have been identified in several IA-PGCG. The clinical course of a frequently locally recurring lesion gives rise to the assumption that lesions of this type show characteristics known in benign neoplasms.

Identifiants

pubmed: 33622887
pii: 35/2/947
doi: 10.21873/invivo.12335
pmc: PMC8045061
doi:

Substances chimiques

KRAS protein, human 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-953

Informations de copyright

Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

J Oral Implantol. 2012 Sep;38 Spec No:527-32
pubmed: 22712772
J Pathol. 2020 Feb;250(2):126-133
pubmed: 31705763
Int J Implant Dent. 2019 Mar 11;5(1):10
pubmed: 30854575
Mol Genet Genomic Med. 2019 May;7(5):e625
pubmed: 30891959
J Med Genet. 2010 Dec;47(12):859-62
pubmed: 20805368
Int J Mol Sci. 2018 Oct 01;19(10):
pubmed: 30275408
J Oral Pathol Med. 2018 May;47(5):454-459
pubmed: 29569293
Swiss Dent J. ;128(12):980-981
pubmed: 30525321
Case Rep Dent. 2015;2015:976756
pubmed: 26788379
Int J Oral Maxillofac Implants. 2004 Mar-Apr;19(2):295-9
pubmed: 15101604
Nat Genet. 2012 Jun 10;44(7):783-7
pubmed: 22683711
Clin Implant Dent Relat Res. 2020 Jun;22(3):366-372
pubmed: 32378812
Rev Belge Med Dent (1984). 2010 Oct-Dec;65(4):152-8
pubmed: 21384627
Anticancer Res. 2010 May;30(5):1645-52
pubmed: 20592356
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):618-22
pubmed: 17141536
Int J Oral Maxillofac Surg. 2010 May;39(5):503-7
pubmed: 20005076
J Oral Biol Craniofac Res. 2019 Jul-Sep;9(3):294-298
pubmed: 31289719
J Periodontol. 2016 May;87(5):502-10
pubmed: 26832832
J Prosthet Dent. 2019 Sep;122(3):181-188
pubmed: 31027952
J Pathol. 2019 May;248(1):116-122
pubmed: 30549028
J Oral Pathol Med. 2011 Apr;40(4):334-7
pubmed: 21029180
Med Oral Patol Oral Cir Bucal. 2019 Nov 1;24(6):e739-e745
pubmed: 31655833
Oral Dis. 1995 Mar;1(1):12-9
pubmed: 7553374
J Oral Implantol. 2016 Feb;42(1):55-60
pubmed: 24059329
BMC Med Genet. 2015 Feb 10;16:6
pubmed: 25928347
Am J Med Genet A. 2016 Feb;170A(2):452-459
pubmed: 26494396
Minerva Stomatol. 2008 Oct;57(10):529-34
pubmed: 19078895
Case Rep Dent. 2015;2015:697673
pubmed: 25861485
J Periodontol. 2003 Sep;74(9):1381-4
pubmed: 14584874
Cell Cycle. 2013 Jan 1;12(1):43-50
pubmed: 23255105
BMC Oral Health. 2019 Dec 16;19(1):283
pubmed: 31842866
J Craniofac Surg. 2013 Nov;24(6):2206-8
pubmed: 24220447
J Investig Clin Dent. 2018 Nov;9(4):e12342
pubmed: 29752778
Clin Adv Periodontics. 2019 Jun;9(2):77-82
pubmed: 31498570
J Am Dent Assoc. 2016 Aug;147(8):646-9
pubmed: 27046538
Cancer Metastasis Rev. 2020 Dec;39(4):1023-1028
pubmed: 32728828
J Craniofac Surg. 2018 Mar;29(2):e196-e199
pubmed: 29303864
J Periodontol. 2009 Jul;80(7):1184-91
pubmed: 19563300
J Stomatol Oral Maxillofac Surg. 2019 Nov;120(5):456-461
pubmed: 30677564
Oral Dis. 2020 Mar;26(2):334-340
pubmed: 31758745
Int J Oral Maxillofac Implants. 2009 Nov-Dec;24(6):1153-6
pubmed: 20162123
J Pathol. 2019 Oct;249(2):173-181
pubmed: 31187483

Auteurs

Reinhard E Friedrich (RE)

Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany; rfriedrich@uke.de.

Falk WÜsthoff (F)

Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.

Andreas M Luebke (AM)

Institute of Pathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.

Felix K Kohlrusch (FK)

Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.

Ilse Wieland (I)

Institute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Martin Zenker (M)

Institute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Martin Gosau (M)

Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH